Atsunori Shindo

Title: Atsunori Shindo: Innovator in Human Tissue Type Plasminogen Activator Production

Introduction

Atsunori Shindo is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of human tissue type plasminogen activator (t-PA). With a total of 2 patents, his work has the potential to impact medical treatments and therapies.

Latest Patents

Atsunori Shindo's latest patents focus on innovative methods for producing human tissue type plasminogen activator. The first patent describes a method that involves producing human t-PA in parallel with cell growth or after the cells have been grown. This method includes the addition of bicarbonate ions to the cell culture at a concentration equivalent to 3 to 10 g/l of NaHCO₃, which increases the osmotic pressure of the medium to a range of 350 to 520 milliosmoles/liter. The second patent also outlines a method for producing human t-PA using a p-aminomethyl benzoic acid derivative in the cell culture medium. This method aims to achieve a high concentration of single-chain t-PA while minimizing the amount of double-chain t-PA in the medium.

Career Highlights

Atsunori Shindo is currently employed at Mitsui Toatsu Chemicals, Incorporated, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving biotechnological processes and enhancing the efficacy of medical treatments.

Collaborations

Atsunori has collaborated with several talented individuals in his field, including Maki Suzuki and Nobumi Kusuhara. These collaborations have contributed to the success of his innovative projects and patents.

Conclusion

Atsunori Shindo's contributions to the field of biotechnology, particularly in the production of human tissue type plasminogen activator, highlight his role as an influential inventor. His innovative methods and dedication to research continue to pave the way for advancements in medical treatments.